Display options
Cite
Sowunmi OA, Amoo G, Onifade PO, et al. Psychoactive substance use among outpatients with severe mental illness: A comparative study. S Afr J Psychiatr. 2019;25:1111doi: 10.4102/sajpsychiatry.v25i0.1111.
Sowunmi, O. A., Amoo, G., Onifade, P. O., Ogunwale, A., & Babalola, E. (2019). Psychoactive substance use among outpatients with severe mental illness: A comparative study. The South African journal of psychiatry : SAJP : the journal of the Society of Psychiatrists of South Africa, 251111. https://doi.org/10.4102/sajpsychiatry.v25i0.1111
Sowunmi, Oladipo A, et al. "Psychoactive substance use among outpatients with severe mental illness: A comparative study." The South African journal of psychiatry : SAJP : the journal of the Society of Psychiatrists of South Africa vol. 25 (2019): 1111. doi: https://doi.org/10.4102/sajpsychiatry.v25i0.1111
Sowunmi OA, Amoo G, Onifade PO, Ogunwale A, Babalola E. Psychoactive substance use among outpatients with severe mental illness: A comparative study. S Afr J Psychiatr. 2019 Sep 30;25:1111. doi: 10.4102/sajpsychiatry.v25i0.1111. eCollection 2019. PMID: 31616577; PMCID: PMC6779966.
Copy Download .nbib Format: NLM
Share it on

S Afr J Psychiatr. 2019 Sep 30;25:1111. doi: 10.4102/sajpsychiatry.v25i0.1111. eCollection 2019.

Psychoactive substance use among outpatients with severe mental illness: A comparative study.

The South African journal of psychiatry : SAJP : the journal of the Society of Psychiatrists of South Africa

Oladipo A Sowunmi, Gbolagade Amoo, Peter O Onifade, Adegboyega Ogunwale, Emmanuel Babalola

Affiliations

  1. Neuropsychiatric Hospital, Aro, Abeokuta, Nigeria.

PMID: 31616577 PMCID: PMC6779966 DOI: 10.4102/sajpsychiatry.v25i0.1111

Abstract

BACKGROUND: Despite several studies on the prevalence and pattern of substance use in Nigeria, there is little information on substance use in patients diagnosed with serious mental illness (SMI) such as schizophrenia and bipolar affective disorder (BD).

AIM: The aim of the study was to compare the pattern of psychoactive substance use among outpatients with BD and schizophrenia.

SETTING: The study was conducted in a neuropsychiatric hospital in Nigeria.

METHODS: Seventy five consecutive patients with a MINI-PLUS diagnosis of BD were compared with an equal number of patients obtained by systematic random sampling with a MINI-PLUS diagnosis of schizophrenia.

RESULTS: The respondents with schizophrenia were aged 18-59 years (37.2 ± 9.99) and were predominantly young adult (49, 65.3%), men (46, 61.3%), who were never married (38, 50.7%). Overall, lifetime drug use prevalence was 52%, while for current use, overall prevalence was 21.3%. Participants with BD were aged 18-63 years (36.7 ± 10.29) and were predominantly young adult (53, 70.7%), women (44, 58.7%), who were married (32, 42.7%), with tertiary education (31, 41.3%). Overall, lifetime drug use prevalence was 46.7%, while current overall prevalence was 17.3%. These rates (lifetime and current) for both diagnostic groups are higher than what was reported by the World Health Organization in the global status report of 2014 (0% - 16%). The statistically significant difference between the two diagnostic groups was related to their sociodemographic and clinical variables and psychoactive substance use.

CONCLUSION: Psychoactive substance use remains a burden in the care of patients diagnosed with schizophrenia and BD. Future policies should incorporate routine screening for substance use at the outpatient department with a view to stemming the tide of this menace.

© 2019. The Authors.

Keywords: bipolar disorder; drug use; psychoactive substance use; schizophrenia; severe mental disorder

Conflict of interest statement

The authors have declared that no competing interests exist.

References

  1. Psychiatry Res. 2011 May 15;187(1-2):185-92 - PubMed
  2. Schizophr Res. 2004 Dec 15;72(1):41-51 - PubMed
  3. J Clin Psychiatry. 2002 Dec;63(12):1180 -1 - PubMed
  4. J Forensic Leg Med. 2013 Nov;20(8):1057-62 - PubMed
  5. Schizophr Res. 2004 Feb 1;66(2-3):115-24 - PubMed
  6. Afr J Psychiatry (Johannesbg). 2010 Mar;13(1):52-7 - PubMed
  7. Schizophr Res. 2011 Mar;126(1-3):270-6 - PubMed
  8. East Afr Med J. 1998 Jan;75(1):19-26 - PubMed
  9. Bipolar Disord. 2001 Aug;3(4):181-8 - PubMed
  10. Int J Addict. 1995 Mar;30(4):445-58 - PubMed
  11. Acta Psychiatr Scand. 1986 Jul;74(1):98-101 - PubMed
  12. Addict Behav. 2005 Aug;30(7):1290-9 - PubMed
  13. Schizophr Res. 2001 Mar 1;48(1):69-82 - PubMed
  14. JAMA. 1990 Nov 21;264(19):2511-8 - PubMed
  15. Schizophr Bull. 1998;24(3):443-55 - PubMed
  16. Arch Gen Psychiatry. 2005 Jun;62(6):593-602 - PubMed
  17. Drug Alcohol Depend. 2007 Nov 2;91(1):1-9 - PubMed
  18. Am J Psychiatry. 1992 Apr;149(4):552-3 - PubMed
  19. Am J Drug Alcohol Abuse. 1989;15(3):291-5 - PubMed
  20. Drug Alcohol Depend. 2011 May 1;115(1-2):120-30 - PubMed
  21. Schizophr Bull. 2009 May;35(3):469-72 - PubMed
  22. Crit Care. 2002 Aug;6(4):335-41 - PubMed
  23. Psychol Med. 2008 Sep;38(9):1241-9 - PubMed
  24. Drug Alcohol Depend. 1993 Oct;33(3):247-56 - PubMed
  25. Schizophr Bull. 2000;26(1):179-92 - PubMed
  26. Schizophr Bull. 1997;23(2):195-201 - PubMed
  27. Int J Soc Psychiatry. 2011 Jul;57(4):418-27 - PubMed
  28. Bipolar Disord. 2008 Sep;10(6):738-41 - PubMed
  29. Bipolar Disord. 2000 Sep;2(3 Pt 2):269-80 - PubMed

Publication Types